Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Hundreds of millions of people worldwide await treatments for rare diseases.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.

Gschwentner and Lackner discuss the advantages of their job share.

The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.

For patients with lung cancer, biomarker testing may be an option.

Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.

A diminutive protein prompts a closer look at DNA dark matter.